Matthew Walter, MD

Articles by Matthew Walter, MD

Identifying Molecular Markers of Relapse in Myelodysplastic Syndrome

ByMeagan A. Jacoby, MD, PhD,Matthew Walter, MD

December 17th 2018

In this month's installment of Ask the PI, ONCOLOGY spoke with Meagan A. Jacoby, MD, PhD, and Matthew Walter, MD, about their findings and what they might mean for practicing oncologists.

Latest Updated Articles

Identifying Molecular Markers of Relapse in Myelodysplastic Syndrome
Published: December 17th 2018 | Updated:

Matthew Walter, MD

Articles by Matthew Walter, MD

Identifying Molecular Markers of Relapse in Myelodysplastic Syndrome

Latest Updated Articles

Trending on CancerNetwork

Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma

Temab-A Displays Early Efficacy in Locally Advanced/Metastatic PDAC

Zanzalintinib Combo Improves Survival in Pretreated Metastatic CRC

Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer

Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC